# Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/oral-hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor-roxadustat-fg-4592/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert Provenzano,Anatole Besarab,Chao Sun,Susan A. Diamond,John H. Durham,José L. Cangiano,Joseph R. Aiello,James E. Novak,Tyson Lee,Robert Leong,Brian K. Roberts,Khalil G. Saikali,Stefan Hemmerich,Lynda A. Szczech,Kin-Hung P. Yu,Thomas B. Neff |
| Citations | 296 |
| DOI | 10.2215/cjn.06890615 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://cjasn.asnjournals.org/content/clinjasn/11/6/982.full.pdf |
| OpenAlex ID | https://openalex.org/W2339445416 |
| PMID | 27094610 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Anatole Besarab](https://scholariq.org/researchers/anatole-besarab/)

## Paper journal

- [Clinical Journal of the American Society of Nephrology](https://scholariq.org/journals/clinical-journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Blood transfusion and management](https://scholariq.org/topics/blood-transfusion-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.